Argenx SE SEC filings ARGX
Argenx SE has 296 filings in SEC EDGAR's recent list, going back to Mar 1, 2017. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 22, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | Aug 27, 2026 | — |
| SC TO-T/A | Filing | Aug 19, 2026 | — |
| SC TO-T/A | Filing | Aug 6, 2026 | — |
| SC TO-T | Filing | Aug 6, 2026 | — |
| SC TO-C | Filing | Jul 28, 2026 | — |
| SC TO-C | Filing | Jul 27, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2025 | — |
| CORRESP | Letter to the SEC | Sep 25, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2025 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| EFFECT | Filing | Dec 13, 2017 | — |
| CORRESP | Letter to the SEC | Dec 11, 2017 | — |
| CORRESP | Letter to the SEC | Dec 11, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2017 | — |
| DRS | Filing | Nov 6, 2017 | — |
| CERTNAS | Auto-generated paper document | May 18, 2017 | — |
| CT ORDER | Filing | May 18, 2017 | — |
| EFFECT | Filing | May 17, 2017 | — |
| UPLOAD | Letter from the SEC | May 17, 2017 | — |
| CERTNAS | Auto-generated paper document | May 17, 2017 | — |
| CORRESP | Letter to the SEC | May 17, 2017 | — |
| 8-A12B | Filing | May 16, 2017 | — |
| CORRESP | Letter to the SEC | May 16, 2017 | — |
| CORRESP | Letter to the SEC | May 16, 2017 | — |
| CORRESP | Letter to the SEC | May 16, 2017 | — |
| UPLOAD | Letter from the SEC | May 15, 2017 | — |
| CORRESP | Letter to the SEC | May 8, 2017 | — |
| UPLOAD | Letter from the SEC | May 5, 2017 | — |
| CORRESP | Letter to the SEC | May 3, 2017 | — |
| UPLOAD | Letter from the SEC | May 3, 2017 | — |
| CORRESP | Letter to the SEC | Apr 21, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2017 | — |
| DRSLTR | Filing | Apr 5, 2017 | — |
| DRS/A | Filing | Apr 5, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2017 | — |
| DRS | Filing | Mar 1, 2017 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ARGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Zwijnaarde
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1697862
- Former names
- argenx N.V (until Apr 21, 2017)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.